Deniz Tural

17PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMolecular targetsCell physiologyCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 08, 2026
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma.

|Aug 18, 2026
Effect of BMI on efficacy of androgen receptor pathway inhibitors in patients with metastatic hormone-sensitive prostate cancer.

|Aug 18, 2026
Global Real-World Outcomes of Olaparib in Metastatic Castration-Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations.

|Apr 22, 2026
The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.

|Sep 02, 2025
Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer.

Caner Kapar, Ilkay Gulturk, Volkan Tugcu

|May 20, 2025
Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers.

Öykü Dila Gemci, Serdar Altınay, İlkay Gültürk

Pageof 3

Frequent Collaborators

4 joint publications

Ilkay Gulturk

4 joint publications

Seher Yıldız Tacar

3 joint publications

Mesut Yılmaz

2 joint publications

Mutlu Hızal